← All trials
NCT06252961
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 21, 2024
- Primary completion
- Sep 18, 2024
- Completion date
- Feb 1, 2026
- First posted
- Feb 12, 2024
- Last posted
- Sep 20, 2024
- Enrollment
- 99
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of CongoLead sponsor
- Government of FranceOfficial
- Government of FranceCollaborator
- Programme National de Lutte contre l'Onchocercose (PNLO)Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.